000			02013nas a22003495i 4500
001			1179-1934
003			DE-He213
005			20260610082520.0
007			cr nn 008mamaa
008			150723s||||||||sz uu poo|||||| b|EN |d
022			_a1179-1934
024	7		_a10.1007/40263.1179-1934 _2doi
210	1	0	_aCNS Drugs
245	1	0	_aCNS Drugs _h[electronic resource] / _cedited by Kate Palmer, Susan Pochon.
264		1	_aCham : _bSpringer International Publishing : _bImprint: Adis.
300			_bonline resource.
520			_aCNS Drugs promotes rational pharmacotherapy within the disciplines of clinical psychiatry and neurology. The Journal includes: Overviews of contentious or emerging issues. Comprehensive narrative reviews that provide an authoritative source of information on pharmacological approaches to managing neurological and psychiatric illnesses. Systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement. Adis Drug Reviews of the properties and place in therapy of both newer and established drugs in neurology and psychiatry. Original research articles reporting the results of well-designed studies with a strong link to clinical practice, such as clinical pharmacodynamic and pharmacokinetic studies, clinical trials, meta-analyses, outcomes research, and pharmacoeconomic and pharmacoepidemiological studies.
650		0	_aNeurology .
650		0	_aPsychiatry.
650		0	_aTherapeutics.
650		0	_aNeurosciences.
650	1	4	_aNeurology.
650	2	4	_aPsychiatry.
650	2	4	_aTherapeutics.
650	2	4	_aNeuroscience.
700	1		_aPalmer, Kate. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aPochon, Susan. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt
710	2		_aSpringerLink (Online service)
776	0	8	_iPrinted version: _x1172-7047
856	4	0	_uhttps://doi.org/10.1007/40263.1179-1934 _zHybrid
999			_c3582 _d3582